Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesInterventions for HIV-associated nephropathy
Cochrane Reviews, 10/20/09
Yahaya I et al. – HIV–associated nephropathy (HIVAN) is a kidney disease common among HIV positive patients, especially patients of African origin. The condition rapidly deteriorates if left untreated. Various treatment options exist, but the benefit of each is unknown. These include: antiretrovirals, steroids, angiotensin–converting enzyme inhibitors (ACEI) and cyclosporin. The aim of this review was to determine the benefits and harms of each treatment option. No completed randomised control trials (RCT) of any interventions for HIVAN were found and so the effects of the treatment options could not be evaluated. However, the results of observational studies identified showed that steroids and ACEI were beneficial in improving the kidney functions of patients. The authors await the results of three ongoing studies, however more RCTs are needed.
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09
Alternative Dosage of Zidovudine in Infants Exposed to Maternal Human Immunodeficiency Virus Infection
The Pediatric Infectious Disease Journal, 10/26/09
Bone health in HIV infection
British Medical Bulletin, 10/30/09
Article Search
Sponsor